|
1
|
Acharya M and Lau-Cam CA: Comparison of
the protective actions of N-acetylcysteine, hypotaurine and taurine
against acetaminophen-induced hepatotoxicity in the rat. J Biomed
Sci. 17(Suppl 1): S352010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Balansky R, Ganchev G, Iltcheva M, Steele
VE and De Flora SD: Prevention of cigarette smoke-induced lung
tumors in mice by budesonide, phenethyl isothiocyanate, and
N-acetylcysteine. Int J Cancer. 126:1047–1054. 2010.PubMed/NCBI
|
|
3
|
Baumgardner JN, Shankar K, Hennings L,
Albano E, Badger TM and Ronis MJ: N-acetylcysteine attenuates
progression of liver pathology in a rat model of nonalcoholic
steatohepatitis. J Nutr. 138:1872–1879. 2008.PubMed/NCBI
|
|
4
|
Arfsten DP, Johnson EW, Wilfong ER, Jung
AE and Bobb AJ: Distribution of radio-labeled N-acetyl-l-cysteine
in Sprague-Dawley rats and its effect on glutathione metabolism
following single and repeat dosing by oral gavage. Cutan Ocul
Toxicol. 26:113–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Atkuri KR, Mantovani JJ and Herzenberg LA
and Herzenberg LA: N-acetylcysteine - a safe antidote for
cysteine/glutathione deficiency. Curr Opin Pharmacol. 7:355–359.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zwingmann C and Bilodeau M: Metabolic
insights into the hepatoprotective role of N-acetylcysteine in
mouse liver. Hepatology. 43:454–463. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Raftos JE, Whillier S, Chapman BE and
Kuchel PW: Kinetics of uptake and deacetylation of N-acetylcysteine
by human erythrocytes. Int J Biochem Cell Biol. 39:1698–1706. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mansour HH, Hafez HF, Fahmy NM and Hanafi
N: Protective effect of N-acetylcysteine against radiation induced
DNA damage and hepatic toxicity in rats. Biochem Pharmacol.
75:773–780. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Slim R, Toborek M, Robertson LW, Lehmler
HJ and Hennig B: Cellular glutathione status modulates
polychlorinated biphenyl-induced stress response and apoptosis in
vascular endothelial cells. Toxicol Appl Pharmacol. 166:36–42.
2000. View Article : Google Scholar
|
|
10
|
Eastman A: Activation of programmed cell
death by anticancer agents: cisplatin as a model system. Cancer
Cells. 2:275–280. 1990.PubMed/NCBI
|
|
11
|
van Moorsel CJ, Pinedo HM, Smid K, et al:
Schedule-dependent pharmacodynamic effects of gemcitabine and
cisplatin in mice bearing Lewis lung murine non-small cell lung
tumours. Eur J Cancer. 36:2420–2429. 2000.PubMed/NCBI
|
|
12
|
Kuhad A, Tirkey N, Pilkhwal S and Chopra
K: Renoprotective effect of Spirulina fusiformis on
cisplatin-induced oxidative stress and renal dysfunction in rats.
Renal Failure. 28:247–254. 2006.
|
|
13
|
Cloven NG, Re A, Mchale MT, et al:
Evaluation of D-methionine as a cytoprotectant in cisplatin
reatment of an animal model for ovarian cancer. Anticancer Res.
20:4205–4209. 2000.PubMed/NCBI
|
|
14
|
Dehne N, Lautermann J, Petrat F, et al:
Cisplatin ototoxicity: involvement of iron and enhanced formation
of superoxide anion radicals. Toxicol Appl Pharmacol. 174:27–34.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thomas Dickey D, Muldoon LL, Kraemer DF,
et al: Protection against cisplatin ototoxicity by N-acetylcysteine
in a rat model. Hear Res. 193:25–30. 2004.PubMed/NCBI
|
|
16
|
Wang FG and Xi JJ: The influence of
acetylcysteine on cytokines of alcoholic liver injury in rat. Chin
J Public Health. 25:336–337. 2009.(In Chinese).
|
|
17
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh NP, McCoy MT, Tice RR and Schneider
EL: A simple technique for quantitation of low levels of DNA damage
in individual cells. Exp Cell Res. 175:184–191. 1988. View Article : Google Scholar
|
|
19
|
Zwelling LA, Anderson T and Kohn KW:
DNA-protein and DNA interstrand cross-linking by cis- and
trans-platinum (II) diamminedichloride in L1210 mouse leukemia
cells and relation to cytotoxicity. Cancer Res. 39:365–369.
1979.PubMed/NCBI
|
|
20
|
Blommaert FA, van Dijk-Knijnenburg HC,
Dijt FJ, et al: Formation of DNA adducts by the anticancer drug
carboplatin: different nucleotide sequence preferences in vitro and
in cells. Biochemistry. 34:8474–8480. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Serpeloni JM, Barcelos GR, Friedmann
Angeli JP, et al: Dietary carotenoid lutein protects against DNA
damage and alterations of the redox status induced by cisplatin in
human derived HepG2 cells. Toxicol In Vitro. 26:288–294. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mistry P, Lee C and McBrien DC:
Intracellular metabolites of cisplatin in the rat kidney. Cancer
Chemother Pharmacol. 24:73–79. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen G, Hutter KJ and Zeller WJ: Positive
correlation between cellular glutathione and acquired cisplatin
resistance in human ovarian cancer cells. Cell Biol Toxicol.
11:273–281. 1995. View Article : Google Scholar
|
|
24
|
Godbout JP, Pesavento J, Hartman ME,
Manson SR and Freund GG: Methylglyoxal enhances cisplatin-induced
cytotoxicity by activating protein kinase Cdelta. J Biol Chem.
277:2554–2561. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu YJ, Muldoon LL and Neuwelt EA: The
chemoprotective agent N-acetylcysteine blocks cisplatin-induced
apoptosis through caspase signaling pathway. J Pharmacol Exp Ther.
312:424–431. 2005.PubMed/NCBI
|
|
26
|
Chirino YI, Trujillo J, Sánchez-González
DJ, et al: Selective iNOS inhibition reduces renal damage induced
by cisplatin. Toxicol Lett. 176:48–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Antunes LM, Darin JD and Bianchi MLP:
Effects of the antioxidants curcumin or selenium on
cisplatin-induced nephrotoxicity and lipid peroxidation in rats.
Pharmacol Res. 43:145–150. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cetin R, Devrim E, Kiliçoğlu B, Avci A, et
al: Cisplatin impairs antioxidant system and causes oxidation in
rat kidney tissues: possible protective roles of natural
antioxidant foods. J Appl Toxicol. 26:42–46. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shan XQ, Aw TY and Jones DP:
Glutathione-dependent protection against oxidative injury.
Pharmacol Ther. 47:61–71. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Powers SK, Quindry JC and Kavazis AN:
Exercise-induced cardioprotection against myocardial
ischemia-reperfusion injury. Free Radic Biol Med. 44:193–201. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishino Y, Takemura S, Minamiyama Y, et
al: Targeting superoxide dismutase to renal proximal tubule cells
attenuates vancomycin-induced nephrotoxicity in rats. Free Radic
Res. 37:373–379. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oktem F, Arslan MK, Ozguner F, Candir O,
Yilmaz HR, et al: In vivo evidences suggesting the role of
oxidative stress in pathogenesis of vancomycin-induced
nephrotoxicity: protection by erdosteine. Toxicology. 215:227–233.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Termini J: Hydroperoxide-induced DNA
damage and mutations. Mutat Res. 450:107–124. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lykkesfeldt J: Malondialdehyde as
biomarker of oxidative damage to lipids caused by smoking. Clin
Chim Acta. 380:50–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mendonça LM, dos Santos GC, dos Santos RA,
et al: Evaluation of curcumin and cisplatin-induced DNA damage in
PC12 cells by the alkaline comet assay. Hum Exp Toxicol.
29:635–643. 2010.PubMed/NCBI
|
|
36
|
Francescato HD, Costa RS, Scavone C and
Coimbra TM: Parthenolide reduces cisplatin-induced renal damage.
Toxicology. 230:64–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao M, Wu NX, Song Y, Jin LZ, Lou JL and
Tao H: PCB153-induced oxidative stress and cell apoptosis on
cultured rat Sertoli cells. Toxicol Res. 2:173–179. 2013.
View Article : Google Scholar
|
